InvestoGain Australia

SEARCH LISTED COMPANY

ANY AUS OR NZ COMPANY

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived funds or use SEARCH

SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

SYNTARA LIMITED(SNT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
SYNTARA LIMITED08/12/2023
PHARMAXIS LTD08/12/2023

Shareholder links

Our website ranking of SNT: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Level 8, 210 George Street, Sydney NSW 2000 GPO Box 3993 Sydney NSW 2001

Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)
Fax : Within Australia: 1300 653 459 Outside Australia: +61 2 9279 0664
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000312480
Address: Unit 2, 10 Rodborough Road, FRENCHS FOREST, NSW, AUSTRALIA, 2086
Tel:  (02) 9454 7200 Fax: (02) 9451 3622

Date first listed: 10/11/2003
Company Secretary: 
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research, development and commercialisation of human therapeutic products that address chronic respiratory and autoimmune diseases and the development of improved lung function tests

News & Events

Expand this box to read and print

The suspension of trading in the securities of Syntara Limited will be lifted from the commencement of trading on 4 August 2025 following the lodgement of its quarterly activity report and quarterly cash flow report for the quarter ended 30 June 2025.

04/08/2025

The company lodges its notice regarding unquoted securities.

04/08/2025

The company releases its quarterly update webinar presentation.

01/08/2025

The company's securities will be suspended from quotation under Listing Rule 17.5 from 1 August 2025 due to not filing a periodic report by the due date. If lodged between market announcements office closure on 31 July 2025 and suspension, securities will be reinstated on the next trading day.

01/08/2025

name changed from Pharmaxis Ltd

08/12/2023

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    21/12/2021Malcolm McComas1,025,000$0.110$112,750.00
    03/05/2021Malcolm McComas500,000$0.087$43,500.00
    02/12/2016Malcolm McComas200,000$0.271$54,167.00
    29/09/2016Gary Phillips-400,000$0.277$110,636.00
    29/10/2013Simon Buckingham200,000$0.124$24,854.00

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Malcolm McComasNon Exec Chairman, Independent Director07/04/2003
    Gary PhillipsCEO, Executive Director12/03/2013
    Tim LuscombeCFO31/08/2024
    Simon GreenIndependent Director16/12/2022
    Hashan De SilvaNon Exec Director16/01/2023
    Kathleen MettersNon Exec Director07/06/2017
    Neil GrahamNon Exec Director04/05/2020
    Cameron BillingsleyCompany Secretary06/02/2025

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.